Cargando…
Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
INTRODUCTION: Angiogenesis is an important factor in the development of osteoarthritis (OA). We investigated the efficacy of bevacizumab, an antibody against vascular endothelial growth factor and an inhibitor of angiogenesis, in the treatment of OA using a rabbit model of anterior cruciate ligament...
Autores principales: | Nagai, Toshihiro, Sato, Masato, Kobayashi, Miyuki, Yokoyama, Munetaka, Tani, Yoshiki, Mochida, Joji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189677/ https://www.ncbi.nlm.nih.gov/pubmed/25230745 http://dx.doi.org/10.1186/s13075-014-0427-y |
Ejemplares similares
-
Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair
por: Nagai, Toshihiro, et al.
Publicado: (2010) -
Usefulness of using laser-induced photoacoustic measurement and 3.0 Tesla MRI to assess knee cartilage damage: a comparison study
por: Ukai, Taku, et al.
Publicado: (2015) -
Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells
por: Jun, Jong Hwa, et al.
Publicado: (2016) -
Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma
por: Amano, Takahiro, et al.
Publicado: (2021) -
Anti‐bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor‐binding response, impairing tumor outgrowth
por: Sanches, Jéssica de Souza, et al.
Publicado: (2016)